Indication
Fexeric is indicated for the control of hyperphosphataemia in adult patients with chronic kidney disease (CKD).
Loading your page…
Loading your page…
Hyperphosphatemia;Renal Dialysis
Marketing Authorisation Holder: Akebia Europe Limited
EMA Authorisation: 23/09/2015
INN: ferric citrate coordination complex
AI Drug & Interaction Analysis
Free account required
Ask Osler about Fexeric: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.